Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors

NCT07292038 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancers

Interventions

DRUG: NM6603

Sponsor

NucMito Pharmaceuticals Co. Ltd.